Kalaris Therapeutics Insider Trades

KLRS

Track insider trading activity from Kalaris Therapeutics executives and directors. See which insiders are buying and selling KLRS stock.

Trades Last 12 Months

KLRS Price

All Insider Trades for Kalaris Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Hallal David Director
Holding Value $40.2k 9,000 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 9,000 shares
$4.72
$4.47
Holding Value $40.2k 9,000 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 9,000 shares
$4.72
$4.47
Holding Value $40.2k 9,000 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 9,000 shares
$4.72
$4.47
Holding Value $40.2k 9,000 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 9,000 shares
$4.72
$4.47
Holding Value $40.2k 9,000 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 9,000 shares
$4.72
$4.47
Dybbs Michael Director
Holding Value $40.2k 9,000 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 9,000 shares
$4.72
$4.47
Adamis Anthony P Director
Holding Value $40.2k 9,000 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 9,000 shares
$4.72
$4.47
Akkaraju Srinivas 10% owner
Holding Value $86.8k 19,408 shares
Last Trade
May 20, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$21.6k 4,471 shares
$4.83
$4.47
Hagen Brett R Chief Accounting Officer
Holding Value $0 0 shares
Last Trade
Mar 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.9k 1,915 shares
$6.72
$4.47
Gall Matthew Chief Financial Officer
Holding Value $425k 95,000 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 95,000 shares
$6.81
$4.47
Feinsod Matthew Chief Medical Officer
Holding Value $603k 135,000 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$919k 135,000 shares
$6.81
$4.47
Oxtoby Andrew See Remarks
Holding Value $992k 222,000 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.51M 222,000 shares
$6.81
$4.47
Holding Value $80.5k 18,000 shares
Last Trade
Apr 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$4.47
Holding Value $80.5k 18,000 shares
Last Trade
Apr 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$4.47
Adamis Anthony P Director
Holding Value $80.5k 18,000 shares
Last Trade
Apr 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$4.47

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up